ROBERTS EIRY

CIK 00017276062 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001727606

Recent Transactions

50 trades

Award
AMICUS THERAPEUTICS, INC.$FOLD
Stock Options (right to buy)
2025-06-05+74,872→ 74,872 total
Award
AMICUS THERAPEUTICS, INC.$FOLD
Common Stock
2025-06-05+20,414→ 76,275 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-02-14$115.04/sh−500→ 35,640 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-02-13$116.74/sh−604→ 34,768 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-02-13−2,113→ 4,227 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-02-13−1,120→ 3,363 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-02-13+1,372→ 36,140 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-02-13−1,372→ 4,115 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-02-13+2,113→ 35,366 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-02-13$116.90/sh−1,114→ 34,252 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-02-13+1,120→ 35,372 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Stock Option
2025-02-12+43,261→ 43,261 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-02-12+8,108→ 8,108 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-02-10$118.22/sh−980→ 33,253 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-02-08+1,860→ 34,233 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-02-08−1,860→ 0 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-01-31−2,769→ 2,769 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-01-31+2,769→ 33,830 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-01-31$152.80/sh−1,457→ 32,373 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Stock Option
2024-12-17+27,770→ 27,770 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2024-12-17+5,487→ 5,487 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-11-08$79.02/sh+1→ 31,061 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Incentive Stock Option
2024-11-08−1→ 1,265 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-11-08$77.81/sh+5,140→ 28,856 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Incentive Stock Option
2024-11-08−971→ 0 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-11-08$81.05/sh+1,233→ 30,089 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Incentive Stock Option
2024-11-08−5,140→ 0 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Incentive Stock Option
2024-11-08−1,233→ 0 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-11-08$102.90/sh+971→ 31,060 total
Award
AMICUS THERAPEUTICS, INC.$FOLD
Common Stock
2024-06-06+11,847→ 55,861 total
Award
AMICUS THERAPEUTICS, INC.$FOLD
Stock Options (right to buy)
2024-06-06+42,467→ 42,467 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-02-13$132.96/sh−1,114→ 23,716 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2024-02-13+4,483→ 4,483 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Stock Option
2024-02-13+22,529→ 22,529 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-02-08$134.21/sh−980→ 22,717 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-02-06$142.24/sh−1,121→ 21,837 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-01-31$140.79/sh−1,457→ 20,832 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2023-12-22$126.74/sh−10,000→ 19,521 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2023-12-12$81.05/sh−6,947→ 39,440 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2023-12-12$120.30/sh−6,978→ 29,521 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2023-12-12$81.05/sh−6,978→ 46,387 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2023-12-12$120.31/sh−6,947→ 29,521 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2023-12-12$81.05/sh+6,947→ 36,468 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2023-12-12$81.05/sh+6,978→ 36,499 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2023-12-08$120.16/sh−200→ 29,521 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2023-12-08$81.05/sh−200→ 53,465 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2023-12-08$81.05/sh−100→ 53,365 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2023-12-08$120.00/sh−100→ 29,521 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2023-12-08$81.05/sh+200→ 29,721 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2023-12-08$81.05/sh+100→ 29,621 total

Companies

Recent Filings

Address

12780 EL CAMINO REAL

SAN DIEGO, CA, 92130

View on SEC.gov